Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024.
- Advertising -
The market “Global Intra-Uterine Contraceptive Devices Market” is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5%in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
For a Free Sample Visit @ databridgemarketresearch.com/reque…nds-forecast-2024
Intra-Uterine Contraceptive Devices Market Categories: Segmentation
Global Intra-Uterine Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD), End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Intra-Uterine Contraceptive Devices Market: Drivers
Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancementsand favourable insurance for IUCD’s.
INCREASED RATE OF UNPLANNED PREGNANCIES
Adolescents most commonly use contraceptive methods with relatively high typical use failure rates such as condoms, withdrawal, or oral contraceptive (OC) pills.
- Advertising -
RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
The increasing number of initiatives taken by the U.S. government has helped to limit the rising number of unplanned pregnancies and abortions rate in the U.S.
In addition, many U.S.-based private firms also contribute towards the solutions for pregnancy-related issues, which include maternal mortality, teenage pregnancies, growing number of abortions, and so on, by promoting the use of contraceptives, such as intrauterine contraceptive devices.
FAVOURABLE INSURANCE FOR IUCD’S
The insurance policy is propelling the Global Intra-Uterine Contraceptive Devices Market towards growth. In Finland, national insurance covers acute but not preventive care, and contraceptives are usually paid by the patient.
In Sweden, the copper IUCDs are available free of cost, whereas hormonal IUCDs are not. All FDA-approved contraceptives in the U.S.
are covered by insurance.
GROWING AWARENESS OF CONTRACEPTIVE
The need to avoid unwanted pregnancies, especially among teenagers, is one of the major drivers for this market. It has also been observed that for over half of the users also identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain and acne, as reasons for use.
This is also one of the factors contributing to the growth of the market in Europe.
Inquiry report @ databridgemarketresearch.com/inqui…nds-forecast-2024
Intra-Uterine Contraceptive Devices Market: Geographic Segmentation
- North America
- South America
- Rest of the World
Intra-Uterine Contraceptive Devices Market: Company Share Analysis
Some of the major players operating in this market are Bayer AG, Teva Pharmaceuticals Industries Ltd., Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltd, Bersil, Amed.
Read more about the Global Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market-industry-trends-forecast-2024/
Table of Content:
- RESEARCH METHODOLOGY
2.2. ARRIVING AT THE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET SIZE
2.3. GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICESMARKET: RESEARCH SNAPSHOT
- MARKET OVERVIEW
- EXECUTIVE SUMMARY
- PREMIUM INSIGHTS
- GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
6.2. HORMONAL IUCD (2013 – 2024)
6.3. COPPER IUCD (2013 – 2024)
- GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
7.1. COUNTRYWISE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
7.1.1. NORTH AMERICA
7.1.3. ASIA-PACIFIC (APAC)
7.1.4. LATIN AMERICA
7.1.5. MIDDLE EAST AND AFRICA
7.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
- GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
8.1. GLOBAL IUCD MARKET: COMPANY SHARE ANALYSIS
8.2. U.S.IUCD MARKET: COMPANY SHARE ANALYSIS
8.3. EUROPE IUCD MARKET: COMPANY SHARE ANALYSIS
8.4. APAC IUCD MARKET: COMPANY SHARE ANALYSIS
8.5. SOUTH AMERICAIUCD MARKET: COMPANY SHARE ANALYSIS
8.6. MIDDLE EAST AND AFRICA IUCD MARKET: COMPANY SHARE ANALYSIS
8.7. MERGERS & ACQUISITIONS
8.8. NEW PRODUCT DEVELOPMENT & APPROVALS
8.10. REGULATORY CHANGES
8.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
- GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
9.1. BAYER HEALTHCARE AG
9.1.2 SWOT ANALYSIS
9.1.3 PRODUCT PORTFOLIO
9.1.4 REVENUE ANALYSIS
9.1.5 ANALYSTS VIEW
9.2. DKT INTERNATIONAL
9.2.2 SWOT ANALYSIS
9.2.3 PRODUCT PORTFOLIO
9.2.4 REVENUE ANALYSIS
9.2.5 ANALYSTS VIEW
9.3. TEVA PHARMACEUTICALS INDUSTRIES, LTD
9.3.2 SWOT ANALYSIS
9.3.3 PRODUCT PORTFOLIO
9.3.4 REVENUE ANALYSIS
9.3.5 ANALYST VIEW
9.4. ALLERGEN, PLC
9.4.2 SWOT ANALYSIS
9.4.3 PRODUCT PORTFOLIO
9.4.4 REVENUE ANALYSIS
9.4.5 ANALYSTS VIEW
9.5. SMB CORPORATION
9.5.2 SWOT ANALYSIS
9.5.3 PRODUCT PORTFOLIO
9.5.4 REVENUE ANALYSIS
9.5.5 ANALYSTS VIEW
9.6. ACTAVIS PLC.
9.6.2 SWOT ANALYSIS
9.6.3 PRODUCT PORTFOLIO
9.6.4 REVENUE ANALYSIS
9.6.5 ANALYSTS VIEW
9.7 OCON MEDICAL LTD.
9.7.2 SWOT ANALYSIS
9.7.3 PRODUCT PORTFOLIO
9.7.4 REVENUE ANALYSIS
9.7.5 ANALYSTS VIEW
9.8 MONALISA NV
9.8.2 SWOT ANALYSIS
9.8.3 PRODUCT PORTFOLIO
9.8.4 REVENUE ANALYSIS
9.8.5 ANALYSTS VIEW
9.9 MEDISAFE DISTRIBUTION, INC.
9.9.2 SWOT ANALYSIS
9.9.3 PRODUCT PORTFOLIO
9.9.4 REVENUE ANALYSIS
9.9.5 ANALYSTS VIEW
9.10 MERIL LIFE SCIENCES PVT. LTD.
9.10.2 SWOT ANALYSIS
9.10.3 PRODUCT PORTFOLIO
9.10.4 REVENUE ANALYSIS
9.10.5 ANALYSTS VIEW
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: